{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T04:14:36Z","timestamp":1760242476331,"version":"build-2065373602"},"reference-count":28,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2017,7,20]],"date-time":"2017-07-20T00:00:00Z","timestamp":1500508800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Nearly 90 years ago, Drury and Szent-Gy\u00f6rgyi revealed that adenosine produced profound hypotension and bradycardia, and it affected kidney function in mammals [1]. [...]<\/jats:p>","DOI":"10.3390\/molecules22071220","type":"journal-article","created":{"date-parts":[[2017,7,20]],"date-time":"2017-07-20T11:21:59Z","timestamp":1500549719000},"page":"1220","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Special Issue: Adenosine Receptors"],"prefix":"10.3390","volume":"22","author":[{"given":"Francisco","family":"Ciruela","sequence":"first","affiliation":[{"name":"Unitat de Farmacologia, Departament Patologia i Terap\u00e8utica Experimental, Facultat de Medicina, IDIBELL-Universitat de Barcelona, L\u2019Hospitalet de Llobregat, 08907 Barcelona, Spain"},{"name":"Institut de Neuroci\u00e8ncies, Universitat de Barcelona, 08035 Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5571-2812","authenticated-orcid":false,"given":"Eddy","family":"Sotelo","sequence":"additional","affiliation":[{"name":"Centro Singular de Investigaci\u00f3n en Qu\u00edmica Biol\u00f3xica e Materiais Moleculares (CIQUS), Universidad de Santiago de Compostela, 15782 Santiago de Compostela, Spain"},{"name":"Departamento de Qu\u00edmica Org\u00e1nica, Facultad de Farmacia, Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2017,7,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1113\/jphysiol.1929.sp002608","article-title":"The physiological activity of adenine compounds with especial reference to their action upon the mammalian heart","volume":"68","author":"Drury","year":"1929","journal-title":"J. Physiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nrd1983","article-title":"Adenosine receptors as therapeutic targets","volume":"5","author":"Jacobson","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_3","unstructured":"Abbracchio, M.P., Wilson, C.N., and Mustafa, S.J. (2009). Adenosine Receptors in Health and Disease: Handbook of Experimental Pharmacology V. 193, Springer."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/0968-0004(84)90176-2","article-title":"Adenosine and the concept of \u201cretaliatory metabolites\u201d","volume":"9","author":"Newby","year":"1984","journal-title":"Trends Biochem. Sci."},{"key":"ref_5","first-page":"261","article-title":"Metabolic Regulation of Blood Flow","volume":"15","author":"Berne","year":"1964","journal-title":"Circ. Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/0002-9343(64)90181-0","article-title":"Renal Hemodynamics","volume":"36","author":"Thurau","year":"1964","journal-title":"Am. J. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1042\/bj1300975","article-title":"Adenine derivatives as neurohumoral agents in the brain. The quantities liberated on excitation of superfused cerebral tissues","volume":"130","author":"Pull","year":"1972","journal-title":"Biochem. J."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0026-895X(25)15197-3","article-title":"The effect of adenosine and adenine nucleotides on the cyclic adenosine 3\u2032,5\u2032-phosphate content of guinea pig cerebral cortex slices","volume":"6","author":"Sattin","year":"1970","journal-title":"Mol. Pharmacol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0022-3565(25)27036-7","article-title":"Effects of Caffeine on Mammalian Atrial Muscle, and its Interaction with Adenosine and Calcium","volume":"148","author":"Degubareff","year":"1965","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/BF00508634","article-title":"Effects of adenosine derivatives on cAMP accumulation and lipolysis in rat adipocytes and on adenylate cyclase in adipocyte plasma membranes","volume":"299","author":"Trost","year":"1977","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1111\/j.1471-4159.1979.tb05236.x","article-title":"Adenosine regulates via two different types of receptors, the accumulation of cyclic AMP in cultured brain cells","volume":"33","author":"Muller","year":"1979","journal-title":"J. Neurochem."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/pr.110.003285","article-title":"International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors\u2014An update","volume":"63","author":"Fredholm","year":"2011","journal-title":"Pharmacol. Rev."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Geldenhuys, W.J., Hanif, A., Yun, J., and Nayeem, M.A. (2017). Exploring Adenosine Receptor Ligands: Potential Role in the Treatment of Cardiovascular Diseases. Molecules, 22.","DOI":"10.3390\/molecules22060917"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Sousa, J., and Diniz, C. (2017). The Adenosinergic System as a Therapeutic Target in the Vasculature: New Ligands and Challenges. Molecules, 22.","DOI":"10.3390\/molecules22050752"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0165-6147(00)01517-0","article-title":"Fine-tuning neuromodulation by adenosine","volume":"21","author":"Sebastiao","year":"2000","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1046\/j.1471-4159.2001.00607.x","article-title":"Adenosine in the central nervous system: Release mechanisms and extracellular concentrations","volume":"79","author":"Latini","year":"2001","journal-title":"J. Neurochem."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/j.1600-0773.1995.tb00135.x","article-title":"Purinoceptors in the nervous system","volume":"76","author":"Fredholm","year":"1995","journal-title":"Pharmacol. Toxicol."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Stockwell, J., Jakova, E., and Cayabyab, F.S. (2017). Adenosine A1 and A2A Receptors in the Brain: Current Research and Their Role in Neurodegeneration. Molecules, 22.","DOI":"10.3390\/molecules22040676"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1523\/JNEUROSCI.3574-05.2006","article-title":"Presynaptic control of striatal glutamatergic neurotransmission by adenosine A1-A2A receptor heteromers","volume":"26","author":"Ciruela","year":"2006","journal-title":"J. Neurosci."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Ciancetta, A., and Jacobson, K. (2017). Structural Probing and Molecular Modeling of the A3 Adenosine Receptor: A Focus on Agonist Binding. Molecules, 22.","DOI":"10.3390\/molecules22030449"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Arin, R.M., Vallejo, A.I., Rueda, Y., Fresnedo, O., and Ochoa, B. (2017). Expression of Adenosine A2B Receptor and Adenosine Deaminase in Rabbit Gastric Mucosa ECL Cells. Molecules, 22.","DOI":"10.3390\/molecules22040625"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Zsuga, J., Erdei, T., Szab\u00f3, K., Lampe, N., Papp, C., Pinter, A., Szentmiklosi, A.J., Juhasz, B., Szilv\u00e1ssy, Z., and Gesztelyi, R. (2017). Methodical Challenges and a Possible Resolution in the Assessment of Receptor Reserve for Adenosine, an Agonist with Short Half-Life. Molecules, 22.","DOI":"10.3390\/molecules22050839"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Deganutti, G., and Moro, S. (2017). Supporting the Identification of Novel Fragment-Based Positive Allosteric Modulators Using a Supervised Molecular Dynamics Approach: A Retrospective Analysis Considering the Human A2A Adenosine Receptor as a Key Example. Molecules, 22.","DOI":"10.3390\/molecules22050818"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Fern\u00e1ndez-Due\u00f1as, V., Azuaje, J., Morat\u00f3, X., Cordobilla, B., Domingo, J., Sotelo, E., and Ciruela, F. (2017). Synthesis and Characterization of a New Bivalent Ligand Combining Caffeine and Docosahexaenoic Acid. Molecules, 22.","DOI":"10.3390\/molecules22030366"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.neubiorev.2016.09.001","article-title":"A review of caffeine\u2019s effects on cognitive, physical and occupational performance","volume":"71","author":"McLellan","year":"2016","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"S205","DOI":"10.3233\/JAD-2010-091459","article-title":"Effects of caffeine in Parkinson\u2019s disease: From neuroprotection to the management of motor and non-motor symptoms","volume":"20","author":"Prediger","year":"2010","journal-title":"JAD"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1021\/cb5005383","article-title":"Uncovering Caffeine\u2019s Adenosine A2A Receptor Inverse Agonism in Experimental Parkinsonism","volume":"9","author":"Taura","year":"2014","journal-title":"ACS Chem. Biol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"19839","DOI":"10.1038\/srep19839","article-title":"Membrane omega-3 fatty acids modulate the oligomerisation kinetics of adenosine A2A and dopamine D2 receptors","volume":"6","author":"Javanainen","year":"2016","journal-title":"Sci. Rep."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/22\/7\/1220\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T18:43:23Z","timestamp":1760208203000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/22\/7\/1220"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,20]]},"references-count":28,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2017,7]]}},"alternative-id":["molecules22071220"],"URL":"https:\/\/doi.org\/10.3390\/molecules22071220","relation":{},"ISSN":["1420-3049"],"issn-type":[{"type":"electronic","value":"1420-3049"}],"subject":[],"published":{"date-parts":[[2017,7,20]]}}}